🇺🇸 FDA
Patent

US 9394358

Gene signature for predicting prognosis of patients with solid tumors

granted A61PA61P35/00

Quick answer

US patent 9394358 (Gene signature for predicting prognosis of patients with solid tumors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00